WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has named Dr. Danielle Meyrick as its new Chief Medical Officer, strengthening its leadership team as it pushes forward with the development of its targeted radiotherapeutic (TRT) pipeline.
A seasoned medical executive, Dr. Meyrick brings over two decades of experience in cancer research and TRT development. She has previously served in senior leadership roles at Telix Pharmaceuticals and ITM Radiopharm, with a focus on advancing radiopharmaceutical candidates from clinical evaluation to regulatory submission.
In her new role, Dr. Meyrick will oversee the clinical strategy for MTTI’s lead programs, EVA101 and EVA102, and help steer the broader EvaThera platform through late-stage development. Her appointment is seen as a key move in the company’s effort to accelerate its oncology pipeline and prepare for commercial readiness.
“My career goal in the TRT area has always been to improve care and outcomes for cancer patients,” said Dr. Meyrick. “Our unique EvaThera platform has demonstrated the ability to enhance delivery of radiation to tumors, minimize off-target activity and reduce dosing requirements — collectively offering a potentially safer, more effective approach to TRT.”
MTTI’s proprietary EvaThera technology is designed to improve precision and safety in targeted radiotherapy by optimizing radiation delivery to tumor sites while minimizing exposure to healthy tissues. EVA101 and EVA102, its lead clinical candidates, are being positioned as next-generation radiopharmaceuticals with the potential to treat a range of cancers more effectively.
“MTTI is delighted to welcome Dr. Danielle Meyrick, an experienced clinician and executive,” said Dr. Chris Pak, President and CEO of MTTI. “Her perspective and track record in TRT development are key complements to our team as we expedite advancement of our targeted radiotherapeutic pipeline.”
Dr. Meyrick’s appointment comes at a pivotal time for MTTI, as it scales its clinical operations and prepares for potential partnerships to support commercialization.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.